Latest Nzx News

Synlait Milk is progressing a key refinancing of its senior bank facilities due June 2026 and plans to replace a $130 million shareholder loan with a two-year term facility. The company reports a preliminary $12 million net loss for the first four months of 2026 amid operational headwinds and asset sales.

Steel & Tube has secured a one-year extension on its ANZ banking facilities, underpinning financial stability as trading conditions soften due to geopolitical tensions and sector-specific pressures.

ArborGen Holdings announces CEO Justin Birch's resignation after three years, appointing Patrick Cumbie as interim CEO while searching for a permanent replacement.

Synlait Milk is on track to refinance its senior bank facilities by June 30, 2026, replacing a $130 million shareholder loan from Bright Dairy with a new two-year loan. The company reported a preliminary net loss of $12 million for the first four months of 2026, reflecting operational headwinds and the recent North Island asset sale.

Ryman Healthcare has launched a NZ$100 million fixed rate bond offer maturing in 2032, aiming to refinance existing debt and diversify its funding sources. The offer includes an exchange mechanism for existing bondholders, with trading in current bonds to be suspended during the transition.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Pacific Edge has secured NZ$36.1 million through a combination of a NZ$25.4 million placement and a significantly oversubscribed retail offer, reinforcing its strategic position to expand the Cxbladder cancer diagnostic platform.

Scales Corporation has declared a final FY2025 dividend of 12.5 cents per share, lifting total dividends for the year to 25 cents, representing 59% of underlying net profit. The company also introduced a Dividend Reinvestment Plan offering shares at a 2% discount.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

AFC Group Holdings reported a sharp 78% drop in revenue to NZ$161,000 and a net loss of NZ$818,000 for FY2026, but secured shareholder backing and plans to expand its wine portfolio and distribution reach.

Green Cross Health plans to sell its Medical division, The Doctors, for NZ$270 million to Tend Health, refocusing on its pharmacy business. Completion hinges on shareholder approval expected by July 2026.

AoFrio Limited has initiated a 1-for-7 renounceable rights offer at NZ$0.07 per share aiming to raise nearly NZ$5 million. This follows a recent $4.56 million placement and supports an aggressive growth strategy targeting $300 million revenue by 2030.